MENU
 

PRE TAX NTA |$3.75

Value as at close of business on 3 January 2024

CIO Insights - 27 September

Hi everyone
 
What a weekend of sport hey! NRL and AFL footy finals, a Wallaby 3-peat (first since 2017), a Ryder Cup for the ages, cycling world championships and the Laver Cup in tennis. Wow! The critics questioned having Sergio Garcia paired with Spanish compatriot Jon Rahm – what an inspired move by Captain Padraig when they were always going to be challenged this weekend. Rory disappoints, while DJ shows what he is made of, despite an ordinary season by his standards!
 
But back to business…
 
Last week I told you how we had just made our most recent 6-monthly series of donations to the various medical research organisations we support, totalling $6.4m. Remember that we make this in lieu of a management fee, and it is calculated as 1.5% p.a. of the Net Tangible Asset value for the period. What I didn’t mention was that we have some new beneficiaries this year, by way of our sixth core manager, TDM Growth Partners. TDM has now been with us for over 12 months, meaning they get to nominate beneficiaries for part of our donation. The new beneficiaries are the Walter and Eliza Research Institute (WEHI), which studies a range of complex diseases from cancers to computational biology, and the Pain Management Research Institute (PMRI) which is focused on the science and management of pain. In future updates I’ll provide more details on the projects we’re supporting in partnership with TDM.

The overwhelming response from our beneficiaries is one of extreme gratitude. The pandemic has changed so many things in our lives and really shone a light on the critical importance of medical research. The ongoing support that HM1 is able to give these incredible organisations is really starting to make an impact on so many people around us.
 
With this in mind, I wanted to make mention of our core managers and make sure everyone properly understands just what an integral part they are to the success of HM1. Firstly, in case you aren’t aware of who they are, here they are:

  1. Caledonia Investments
  2. Cooper Investors
  3. Magellan
  4. Paradice Investment Management
  5. Regal Funds Management
  6. TDM Growth Partners


I’m sure you’ve heard of all or most of these managers – they are amongst the best in the industry, each with very long and enviable track records of their own. Not all of them are open for new investments, yet they all support HM1 in a big way.
 
Firstly, their investment recommendations represent 65% of where we invest our portfolio, which is twice the amount we invest in the conference recommendations made each year. Obviously, this shows the relative importance of the core portfolio to the overall success of the portfolio. Each manager gives HM1 their three highest conviction stock recommendations across their own portfolios. Unlike the conference stocks, these positions can and are usually held for far longer than the 12-month maximum holding period of the conference portfolio. Not surprisingly, there are still quite a few holdings that we purchased at inception, way back in late 2018. These are investments where compounding is more able to take place and have business models that should just keep on keeping on over many years.
 
Our core managers provide this intellectual property for no charge at all, as they see that the better the portfolio performs, the bigger the overall donation becomes, and each core manager is able to direct a portion of the donation (just under 10% each) to a medical research institute(s) of their choice. As with all of us, our managers each have some sort of personal connection with an illness or affliction, and so are able to use HM1 as a way of supporting the causes of their choice and using their investment skills to do so. That’s why I say we have such alignment of interests within HM1 – we are not trying to profit by earning management or performance fees, rather we are trying to deliver our shareholders satisfactory investment returns and make a philanthropic impact where we can.
 
Of course, things don’t always play out as we would all like, and things change, whether it be because of the pandemic, Governments suddenly imposing new rules or tariffs on businesses, new competitors emerging, or some other roadblock. These things happen, and that’s investing. And that’s why we cannot and do not sit passively during the year. One of our managers described it well one day when he said “panic early” when something big happens, like, say a government moving the goalposts for an industry. Even though we don’t alter the core portfolio to the same extent as the conference portfolio, we are always in touch with each of our core managers, especially in the more volatile times we see from time to time. They care deeply about the success of HM1, and are doing their absolute best to see that shareholders and beneficiaries get the best outcome possible.
 
Whilst the conference portfolio is a smaller part of the overall portfolio it is nonetheless extremely valuable, as you have seen through many of the amazing returns the stocks have delivered. It aims to give our portfolio some X-factor if you like – stock recommendations where the managers have identified likely catalysts in the nearer term for a share price rise. Of course, like with our core holdings, goalposts shift, and with less time for the catalysts to eventuate, sometimes we see that stocks don’t perform. And this is ok. Without the benefit of a crystal ball, nothing in life (investment or otherwise) is guaranteed, and so each day every investment is re-assessed, and if conviction is lost, or the initial catalyst no longer looks like eventuating, we cut and move on.
 
Simple, but effective.
 
With end of month coming up, I’ll be back with more insights and conference details in a couple of weeks.
 


Stay safe

Rory Lucas
Chief Investment Officer
Hearts and Minds Investments Limited

Reminder: these are simply my general views and should not be taken as investment advice

 

If you would like to receive these weekly updates direct to your inbox each Monday, sign up here.

 

DISCLAIMER: This communication has been prepared by Hearts and Minds Investments Limited (ABN 61 628 753 220). In preparing this document the investment objectives, financial situation or particular needs of an individual have not been considered. You should not rely on the opinions, advice, recommendations and other information contained in this publication alone. This publication has been prepared to provide you with general information only. It is not intended to take the place of professional advice and you should not take action on specific issues in reliance on this information. Past performance is not a reliable indicator of future performance. This document may not be reproduced or copies circulated without prior authority from Hearts and Minds Investments Limited.

 

 

Recent Posts

Read the latest insights
A curated list of HM1 investor updates, portfolio news and other interesting articles.
Read More
10 top fund managers reveal their long-term stock picks
With valuations stretched and geopolitical tensions high, the new year offers plenty of potholes for investors. 
Rikki Bannan – Don’t get caught up in momentum
Conference Fund Manager Rikki Bannan, Executive Director at IFM Investors, joins Equity Mates to discuss her standout 2023 stock pick, Telix, and explore what opportunities lie ahead.
Professor Jane Butler: Sparking Hope for Spinal Cord Injuries
In this episode of the Hearts & Minds Podcast, we sit down with Professor Jane Butler to discuss her groundbreaking research into spinal cord injuries.
Nick Griffin – The Nvidia story is not over
Nick Griffin, Founding Partner & Chief Investment Officer of Munro Partners joined the Equity Mates podcast in their Summer Series.
 

10 top fund managers reveal their long-term stock picks

With valuations stretched and geopolitical tensions high, the new year offers plenty of potholes for investors. 

Read More
December 28th, 2024
 

Rikki Bannan – Don’t get caught up in momentum

Conference Fund Manager Rikki Bannan, Executive Director at IFM Investors, joins Equity Mates to discuss her standout 2023 stock pick, Telix, and explore what opportunities lie ahead.

Read More
December 19th, 2024
 

Professor Jane Butler: Sparking Hope for Spinal Cord Injuries

In this episode of the Hearts & Minds Podcast, we sit down with Professor Jane Butler to discuss her groundbreaking research into spinal cord injuries.

Read More
December 10th, 2024
 

Nick Griffin – The Nvidia story is not over

Nick Griffin, Founding Partner & Chief Investment Officer of Munro Partners joined the Equity Mates podcast in their Summer Series.

Read More
December 9th, 2024
 

HM1 CEO Succession

Hearts and Minds Investments Limited advises that Paul Rayson intends to retire from the position of Chief Executive Officer, effective 19 February 2025.

Read More
December 5th, 2024
 

Trump unifies top investors in decade-long bullish outlook for US

Nick Moakes, CIO of the $72 billion Wellcome Trust, told the conference that too many investors were banking on a return to the ultra-low interest rates that prevailed over the past decade.

Read More
November 20th, 2024
 

These rock-star stock picks could get markets talking next year

Eleven rock stars of international and local funds management took to stage – each tasked with picking and pitching one company whose shares will take off over the next year.

Read More
November 18th, 2024
 

Is anyone brave or stupid enough to bet against America?

Stock pickers have been punished for betting against the US. The choice between consensus and contrarianism on American exceptionalism is now harder than ever.

Read More
November 17th, 2024
 

Sohn: NYSE-listed Estee Lauder’s Northcape Capital pick

Northcape Capital’s Fleur Wright this gives a rare opportunity to buy a high quality company at an attractive price.

Read More
November 15th, 2024
 

Sohn ASX stock pick: Ellerston Capital’s Chris Kourtis backs Perpetual

Chris Kourtis has put his biggest bet on embattled Perpetual – picking one of the most hated stocks on the ASX – that he believes will soon be the ‘cheapest listed asset manager of scale in the universe’.

Read More
November 15th, 2024
 

AI start-ups a threat to incumbent big companies

Paul Bassat predicts emerging artificial intelligence companies will disrupt sectors and overtake established incumbent companies just as rapidly as the seismic shifts that took place when the internet emerged in the mid-1990s.

Read More
November 15th, 2024
 

Howard Marks and Sohn’s big stars reveal seven rules for investing

Among the stock picks and stunts at the Sohh Hearts & Minds event, Howard Marks and Nick Moakes provided investors with long-term rules for playing markets.

Read More
November 15th, 2024
 

Sohn investors position for bullish but bumpy Trump ride

Australia and the rest of the world must adjust to a new Trump presidency that will deliver an expected bull market but also disruption, with the leader in waiting prepared to “create pain” to get his way.

Read More
November 15th, 2024
 

Sohn stock picker experts name best shares to invest in for year ahead

‍Don’t overlook down and out silver miners, legacy skincare brands ready for a revival and a big financial company suffering from a severe case of shareholder wealth destruction.

Read More
November 15th, 2024
 

Eleven stock tips from Sohn to get you through 2025

“There’s no finer place for the finance festival than in the festival city,” said Matthew Grounds. He, along with fellow Barrenjoey co-executive chairman Guy Fowler and investor Gary Weiss, is one of Sohn’s driving forces.

Read More
November 15th, 2024
 

Sohn Hearts & Minds Investments fund targets $1.5bn valuation

‍Hearts & Minds Investments chair Chris Cuffe is hoping for HM1 to grow to more than $1.5bn in the next five years.

Read More
November 14th, 2024
 

Galaxy Digital CEO Mike Novogratz believes bitcoin will hit $US100k

Bitcoin’s bounce to record highs in recent days is only the beginning of a fresh surge higher for cryptocurrency, says US billionaire Mike Novogratz.

Read More
November 9th, 2024
 

Why this New York hedge fund manager sees opportunity in European stocks

Influential New York-hedge fund manager Ricky Sandler will turn to Europe for his next stock pick.

Read More
November 6th, 2024
 

Antipodes’ Ross says short-term wealth hinges on US election

The portfolio manager says defensive stocks pose a bigger risk than the magnificent seven for investors that are overexposed to the American sharemarket.

Read More
November 5th, 2024
 

Concentration risk key for investors: Antipodes Partners’ Vihari Ross

The concentration risk in global stock indexes that has built up during the strong rise over the past year must now be a key consideration for global investors, according to Vihari Ross.

Read More
November 5th, 2024
 

The fundie betting big on China – with help from AI

Mr Mehta is sticking to his well-worn strategy: he’s hunting for companies across Asia that aren’t battling intense competition and have management teams focused on costs, cash generation and high payouts to shareholders.

Read More
November 5th, 2024
 

Why this fundie wants you to ‘wince’ at his stock picks

When fund managers come to pitch their favourite stock at the annual Sohn Hearts & Minds conference, there are two ways they can go: they can play it safe, or they can take a risk and shock the room.

 

Read More
October 29th, 2024
 

IFM Investors’ Rikki Bannan backs small cap investments to rebound after mixed performance

IFM Investors executive director Rikki Bannan believes this year could be a good one to invest in some select small cap stocks.

Read More
October 27th, 2024
 

Meet the 2024 Conference Managers

Following a global search, the Conference Fund Manager Selection Committee is pleased to share eleven new managers for 2024. 

Read More
October 22nd, 2024
 

Chris Kourtis is on a winning streak. Here’s his next ASX pick

Chris Kourtis of Ellerston Capital thinks he’s found another winner and thinks it’s the last chance to have a bite at the cherry before the strategy plays out.

Read More
October 21st, 2024
 

Why Ellerston Capital’s Chris Kourtis plans to back a ‘hated’ stock

Chris Kourtis of Ellerston Capital plans to tip one of the “most hated” stocks in Australia when he presents at the 2024 Sohn Hearts & Minds Conference.

Read More
October 21st, 2024
 

Alex Pollak champions rewards of disruptive investment

Alex Pollak’s funds management company Loftus Peak rode the Nvidia wave and he is now looking at more opportunities in disruptive industry stocks.

Read More
October 14th, 2024
 

Buy Hold Sell: 2 Hall of Fame investors analyse each other's best ideas

Hall of Fame alumni Chris Kourtis of Ellerston Capital joins Livewire to analyse high conviction stock picks.

Read More
October 11th, 2024
 

Sumit Gautam - Why AI won't deliver in 2025 | Scalar Gauge

Sumit Gautam is the Founder of Scalar Gauge and speaks with Equity Mates ahead of his appearance at the Sohn Hearts & Minds conference.

Read More
October 8th, 2024
 

Missed out on Nvidia and Ozempic? This fundie says it’s never too late

Northcape Capital’s Fleur Wright is still kicking herself for not owning market darlings Nvidia and Novo Nordisk, the maker of the weight loss wonder drug Ozempic, before shares of those companies rocketed in 2023.

Read More
September 30th, 2024